Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF

AIMS: The aim of this study was to examine the effect of dapagliflozin on the incidence of ventricular arrhythmias and sudden death in patients with heart failure and reduced ejection fraction (HFrEF). METHODS AND RESULTS: In a post hoc analysis of DAPA-HF, we examined serious adverse event reports...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtain, James P, Docherty, Kieran F, Jhund, Pardeep S, Petrie, Mark C, Inzucchi, Silvio E, Køber, Lars, Kosiborod, Mikhail N, Martinez, Felipe A, Ponikowski, Piotr, Sabatine, Marc S, Bengtsson, Olof, Langkilde, Anna Maria, Sjöstrand, Mikaela, Solomon, Scott D, McMurray, John J V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Fast Track Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455345/
https://www.ncbi.nlm.nih.gov/pubmed/34448003
http://dx.doi.org/10.1093/eurheartj/ehab560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455345/
https://www.ncbi.nlm.nih.gov/pubmed/34448003
http://dx.doi.org/10.1093/eurheartj/ehab560

Ejemplares similares